Gufic BioScience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
355.60
-2.25 (-0.63%)
BSENSE

Dec 05

BSE+NSE Vol: 19.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
10.13
10.03
Share Warrants & Outstandings
Total Reserve
590.94
522.53
Shareholder's Funds
601.08
532.56
Minority Interest
0.00
0.00
Long-Term Borrowings
130.50
153.96
Secured Loans
130.50
153.96
Unsecured Loans
0.00
0.00
Deferred Tax Assets / Liabilities
7.77
2.06
Other Long Term Liabilities
24.97
16.53
Long Term Trade Payables
0.00
0.00
Long Term Provisions
17.49
15.38
Total Non-Current Liabilities
180.73
187.93
Current Liabilities
Trade Payables
158.75
166.27
Other Current Liabilities
44.53
37.97
Short Term Borrowings
179.88
163.07
Short Term Provisions
4.40
4.74
Total Current Liabilities
387.56
372.05
Total Liabilities
1,169.36
1,092.54
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
558.16
206.64
Less: Accumulated Depreciation
76.64
62.74
Less : Impairment of Assets
0.00
0.00
Net Block
481.52
143.91
Lease Adjustment
0.00
0.00
Capital Work in Progress
21.82
307.06
Intangible assets under development
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
1.78
1.78
Long Term Loans & Advances
13.18
23.12
Other Non Current Assets
2.06
1.21
Total Non-Current Assets
544.84
492.06
Current Assets Loans & Advances
Current Investments
0.00
0.00
Inventories
216.87
200.48
Sundry Debtors
314.61
329.94
Cash and Bank
29.02
13.48
Other Current Assets
3.07
3.75
Short Term Loans and Advances
60.95
52.83
Total Current Assets
624.52
600.48
Net Current Assets (Including Current Investments)
236.97
228.43
Total Current Assets Excluding Current Investments
624.52
600.48
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
1,169.36
1,092.54
Contingent Liabilities
5.86
6.62
Total Debt
310.37
317.03
Book Value per share (adjusted)
59.93
53.11
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -2.10% vs NA in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 51.06% vs NA in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 11.62% vs NA in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 4.00% vs NA in Mar 2024

Compare Balance Sheet Results of Gufic BioScience
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.13
46.05
-35.92
-78.00%
Share Warrants & Outstandings
Total Reserve
590.94
740.13
-149.19
-20.16%
Shareholder's Funds
601.08
786.18
-185.10
-23.54%
Minority Interest
0.00
26.06
-26.06
-100.00%
Long-Term Borrowings
130.50
162.46
-31.96
-19.67%
Secured Loans
130.50
80.78
49.72
61.55%
Unsecured Loans
0.00
81.68
-81.68
-100.00%
Deferred Tax Assets / Liabilities
7.77
-18.67
26.44
141.62%
Other Long Term Liabilities
24.97
8.20
16.77
204.51%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
17.49
3.26
14.23
436.50%
Total Non-Current Liabilities
180.73
155.25
25.48
16.41%
Current Liabilities
Trade Payables
158.75
67.22
91.53
136.16%
Other Current Liabilities
44.53
29.12
15.41
52.92%
Short Term Borrowings
179.88
142.30
37.58
26.41%
Short Term Provisions
4.40
2.06
2.34
113.59%
Total Current Liabilities
387.56
240.70
146.86
61.01%
Total Liabilities
1,169.36
1,208.19
-38.83
-3.21%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
558.16
318.78
239.38
75.09%
Less: Accumulated Depreciation
76.64
27.45
49.19
179.20%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
481.52
291.33
190.19
65.28%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
21.82
44.17
-22.35
-50.60%
Intangible assets under development
0.00
128.33
-128.33
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
1.78
0.01
1.77
17,700.00%
Long Term Loans & Advances
13.18
9.99
3.19
31.93%
Other Non Current Assets
2.06
2.57
-0.51
-19.84%
Total Non-Current Assets
544.84
485.76
59.08
12.16%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
216.87
56.63
160.24
282.96%
Sundry Debtors
314.61
123.88
190.73
153.96%
Cash and Bank
29.02
385.50
-356.48
-92.47%
Other Current Assets
3.07
124.15
-121.08
-97.53%
Short Term Loans and Advances
60.95
32.27
28.68
88.88%
Total Current Assets
624.52
722.43
-97.91
-13.55%
Net Current Assets (Including Current Investments)
236.97
481.73
-244.76
-50.81%
Total Current Assets Excluding Current Investments
624.52
722.43
-97.91
-13.55%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,169.36
1,208.19
-38.83
-3.21%
Contingent Liabilities
5.86
20.93
-15.07
-72.00%
Total Debt
310.37
304.76
5.61
1.84%
Book Value per share (adjusted)
59.93
170.72
-110.79
-64.90%
Annual - Borrowings
Borrowings 310.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.10% vs NA in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 24.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 51.06% vs NA in Mar 2024

Annual - Fixed Assets
Fixed Assets 503.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.62% vs NA in Mar 2024

Annual - Investments
Investments 1.78 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024

Annual - Current Assets
Current Assets 624.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.00% vs NA in Mar 2024